Trial Profile
A phase II study evaluating the safety and effectiveness of ABT-510 in subjects with refractory lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2007
Price :
$35
*
At a glance
- Drugs ABT 510 (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
- 23 Aug 2007 Status change
- 25 Sep 2005 New trial record.